“…In the past 10 years, we focused on the investigation of the CT interaction of numerous vital and biological active molecules with different kinds of acceptors [82] , [83] , [84] , [85] , [86] , [87] , [88] , [89] , [90] , [91] , [92] , [93] , [94] , [95] , [96] , [97] , [98] , [99] , [100] , [101] , [102] , [103] , [104] , [105] , [106] , [107] , [108] , [109] , [110] . Now, we seek to explore the CT complexation of two anti-inflammatory glucocorticosteroid compounds, hydrocortisone (HC) and dexamethasone (DM), currently used as adjunctive therapeutics in the treatment of COVID-19 in a series of related publications.…”